Help protect your adolescent patients from meningococcal disease

have caused almost all cases of meningococcal disease in the United States10:
A, C, W, Y, and B
Serogroup B alone contributes to a significant number of cases of meningococcal disease.11
help protect against the 5 vaccine-preventable serogroups1
Your adolescent patients need 2 different vaccines to help protect them from meningococcal disease—one for serogroups A, C, W-135, and Y and one for serogroup B1

*In patients aged <1 to ≥65 years, from 2005-2014; N=867.
Includes serogroup W-135 and serogroups unable to be identified.

Vaccination may not protect all recipients.

References: 1. Meningococcal vaccines for preteens, teens. Centers for Disease Control and Prevention website. Updated April 18, 2016. Accessed April 7, 2017. 2. Meningococcal disease. In: Hamborsky J, Kroger A, Wolfe S, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Washington, DC: Public Health Foundation; 2015;261-278. Accessed April 7, 2017. 3. Pelton SI. Meningococcal disease awareness: clinical and epidemiological factors affecting prevention and management in adolescents. J Adolesc Health. 2010;46:S9-S15. 4. Slack R, Hawkins KC, Gilhooley L, Addison GM, Lewis MA, Webb NJA. Long-term outcome of meningococcal sepsis-associated acute renal failure. Pediatr Crit Care Med. 2005;6(4):477-479. 5. Vyse A, Anonychuk A, Jäkel A, et al. The burden and impact of severe and long-term sequelae of meningococcal disease. Expert Rev Anti Infect Ther. 2013;11(6):597-604. 6. Cohn AC, MacNeil JR, Clark TA, et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2013;62(RR-2):1-28. 7. MacNeil J, Cohn A. Meningococcal disease. In: Roush SW, Baldy LM, eds. Manual for the Surveillance of Vaccine-Preventable Diseases. 6th ed. Updated April 1, 2014. Accessed May 27, 2016. 8. Granoff DM, Harrison LH, Borrow R. Meningococcal vaccines. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 5th ed. Philadelphia, PA: Saunders; 2008:399-434. 9. Thompson MJ, Ninis N, Perera R, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006;367(9508):397-403. 10. Meningococcal disease: causes and transmission. Centers for Disease Control and Prevention website. Updated June 11, 2015. Accessed May 27, 2016. 11. Centers for Disease Control and Prevention. Active bacterial core surveillance (ABCs). Neisseria meningitidis, 2005-2014. Centers for Disease Control and Prevention website. Accessed May 27, 2016.

818041R0 March 2017